This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newell-Price, J. Articles by Clark, A. J. L. Search for Related Content PubMed PubMed Citation Articles by Newell-Price, J. Articles by Clark, A. J. L.

The CpG Island Promoter of the Human Proopiomelanocortin Gene Is Methylated in Nonexpressing Normal Tissue and Tumors and Represses Expression

Section of Medicine (J.N.-P.) Sheffield University, Clinical Sciences Northern General Hospital Sheffield, S5 7AU, United Kingdom
Departments of Endocrinology (P.K., A.J.L.C.) St Bartholomew’s and Royal London School of Medicine and Dentistry West Smithfield, London, EC1A 7BE, United Kingdom

Ectopic secretion of ACTH, from sites such as small cell lung cancer (SCLC), results in severe Cushing’s syndrome. ACTH is cleaved from POMC. The syndrome may occur when the highly tissue-specific promoter of the human POMC gene (POMC) is activated. The mechanism of activation is not fully understood. This promoter is embedded within a defined CpG island, and CpG islands are usually considered to be unmethylated in all tissues. We demonstrate that much of this CpG island is methylated in normal nonexpressing tissues, in contrast to somatically expressed CpG island promoters reported to date, and is specifically unmethylated in expressing tissues, tumors, and the POMC-expressing DMS-79 SCLC cell line. A narrow 100-bp region is free of methylation in all tissues. E2F factors binding to the upstream domain IV region of the promoter have been shown to be involved in the expression of POMC in SCLC. We show that these sites are methylated in normal nonexpressing tissues, which will prevent binding of E2F, but are unmethylated in expressing tissue. Methylation in vitro is sufficient for silencing of expression, which is not reversed by treatment with Trichostatin A, suggesting that inhibition of expression may be mediated by means other than recruitment of histone deacetylase activity. The DMS-79 cells lack POMC demethylating activity, implying that the methylation and expression patterns are likely to be set early or before neoplastic transformation, and that targeted de novo methylation might be a potential therapeutic strategy.

This article has been cited by other articles:

				A. Plagemann, T. Harder, M. Brunn, A. Harder, K. Roepke, M. Wittrock-Staar, T. Ziska, K. Schellong, E. Rodekamp, K. Melchior, et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome J. Physiol., October 15, 2009; 587(20): 4963 - 4976. [Abstract] [Full Text] [PDF]

				M. Kawaguchi, T. Toyama, R. Kaneko, T. Hirayama, Y. Kawamura, and T. Yagi Relationship between DNA Methylation States and Transcription of Individual Isoforms Encoded by the Protocadherin-{alpha} Gene Cluster J. Biol. Chem., May 2, 2008; 283(18): 12064 - 12075. [Abstract] [Full Text] [PDF]

				M. Suzuki, S. Sato, Y. Arai, T. Shinohara, S. Tanaka, J. M. Greally, N. Hattori, and K. Shiota A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse. Genes Cells, December 1, 2007; 12(12): 1305 - 1314. [Abstract] [Full Text] [PDF]

				H. Sakamoto, M. Suzuki, T. Abe, T. Hosoyama, E. Himeno, S. Tanaka, J. M Greally, N. Hattori, S. Yagi, and K. Shiota Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity Genes Cells, October 1, 2007; 12(10): 1123 - 1132. [Abstract] [Full Text] [PDF]

				G.-S. Liu, L.-F. Liu, C.-J. Lin, J.-C. Tseng, M.-J. Chuang, H.-C. Lam, J.-K. Lee, L.-C. Yang, J. H. Y. Chan, S.-L. Howng, et al. Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of {alpha}-Melanocyte-Stimulating Hormone-Mediated Inhibition of the Nuclear Factor {kappa}B/Cyclooxygenase-2 Pathway Mol. Pharmacol., February 1, 2006; 69(2): 440 - 451. [Abstract] [Full Text] [PDF]

				L. Ye, X. Li, X. Kong, W. Wang, Y. Bi, L. Hu, B. Cui, X. Li, and G. Ning Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids J. Endocrinol., May 1, 2005; 185(2): 337 - 343. [Abstract] [Full Text] [PDF]

				N. Hattori, T. Abe, N. Hattori, M. Suzuki, T. Matsuyama, S. Yoshida, E. Li, and K. Shiota Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem Cells Genome Res., September 1, 2004; 14(9): 1733 - 1740. [Abstract] [Full Text] [PDF]

				N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma Cancer Res., July 15, 2003; 63(14): 4158 - 4166. [Abstract] [Full Text] [PDF]

				R. P. Friday, S. L. Pietropaolo, J. Profozich, M. Trucco, and M. Pietropaolo Alternative Core Promoters Regulate Tissue-specific Transcription from the Autoimmune Diabetes-related ICA1 (ICA69) Gene Locus J. Biol. Chem., January 3, 2003; 278(2): 853 - 863. [Abstract] [Full Text] [PDF]

				V. Mynard, L. Guignat, J. Devin-Leclerc, X. Bertagna, and M. G. Catelli Different Mechanisms for Leukemia Inhibitory Factor-Dependent Activation of Two Proopiomelanocortin Promoter Regions Endocrinology, October 1, 2002; 143(10): 3916 - 3924. [Abstract] [Full Text] [PDF]

				A. L. B. Cabral, K. S. Lee, and V. R. Martins Regulation of the Cellular Prion Protein Gene Expression Depends on Chromatin Conformation J. Biol. Chem., February 8, 2002; 277(7): 5675 - 5682. [Abstract] [Full Text] [PDF]